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FeverAbstract Background: Familial hemophagocytic lymphohistiocytosis is a rare autosomal reces-
sive disease that is usually evident in the first few months or years of life. Major signs and symptoms
include hepatomegaly, splenomegaly, anemia, leucopenia or thrombocytopenias which resemble
many inborn errors of metabolism and lysosomal storage diseases in which hemophagocytic lym-
phohistiocytosis has also been reported as a secondary association.
Case reports: We report three children with hemophagocytic lymphohistiocytosis for whom
mutation screening for the known four genes of FHL ((PRF1 (FHL2), UNC13D (FHL3), STX11
(FHL4), and STXBP2 (FHL5)) revealed no mutation, while sequencing of the LIPA gene con-
firmed the diagnosis of Wolman disease. Peculiar characteristics of these patients included absence
of prominent fever, huge hepatomegaly and a severe failure to thrive.
Conclusion: Wolman disease should be excluded in patients with clinical and laboratory charac-
teristics of FHL and negative molecular testing especially if the fever is not prominent and is asso-
ciated with relatively huge hepatomegaly and/or severe failure to thrive.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Familial hemophagocytic lymphohistiocytosis (FHL) presents
within the first months or years of life with prolonged fever
(more than 7 days), cytopenias, hepatosplenomegaly, liver dys-
function, neurological dysfunction and hemophagocytic cellsin the bone marrow [1]. Secondary (acquired or reactive)
hemophagocytic lymphohistiocytosis (HLH) is difficult to dis-
tinguish from FHL (primary) by clinical or histologic findings
alone. The diagnosis of secondary HLH is usually made in
association with infection by viruses, bacteria, fungi, or para-
sites or in association with lymphoma, autoimmune disease,
or metabolic disease [2,3]. Inborn errors of metabolism includ-
ing biotinidase deficiency [4], lysinuric protein intolerance [5],
galactosemia [6], multiple sulfatase deficiency, Gaucher
disease, Pearson syndrome, galactosialidosis, methylmalonic
acidemia, and propionic acidemia [7] have all been reported
Figure 1 Family pedigree of patient (2).
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main challenge to the physician in these cases is the diagnosis
of the underlying IEM.
1.1. Case report (1)
Is a 2.5 month old boy, the second in birth order of double
cousin parents who presented at the age of one month with
abdominal distension. He had a history of mild fever for the
last 5 days (37.7 C). On examination, the patient’s weight
was 3 kg (birth weight was 3.250 kg), he had huge
hepatomegaly and pallor. CBC showed hemoglobin level of
5 g/dl, total white blood cell count (WBC) of 3800/ll and
platelets of 98,000/mm3. Bone marrow aspiration revealed
moderate hypercellular bone marrow. Erythropoiesis was the
most stimulated and showed abundance of the marrow precur-
sors. Late normoblasts showed defective hemoglobinization
and deficient stainable iron. Granulocytopoiesis was stimu-
lated to a lesser extent and showed normal morphology and
normal maturation sequence. Myeloblasts were 2% of the
nucleated marrow elements. The myeloid: erythroid series ratio
was decreased to 1.7: (1) Megakaryocytes were increased and
showed occasional young forms. Free platelets were decreased
in count. Lymphocytes were normal in count (11%) and mor-
phology. Plasma cells were normal, macrophages were mark-
edly increased and showed features of activation with
phagocytosis of intact blood cells and marrow elements.
Serum ferritin was 2363 ng/ml (normal; range 10–120),
serum LDH was 1612 U/L (normal range 266–500), and serum
triglyceride was 528 mg/dl. EBV IGM and CMV IgM were
both negative
Abdominal ultrasound revealed markedly enlarged liver
measuring 9.8 cm in span in mid clavicular line with homoge-
nous echopattern with no focal lesion and no dilatation of
intrahepatic or extrahepatic bile ducts. The spleen was mildly
enlarged measuring 11.2 cm in its long axis with no focal
lesions. Both kidneys showed normal site, size and shape with
normal thickness and echopattern, with no stones or back
pressure changes. Pancreas and para aortic region were free.
There was no ascites, no abdominal or pelvic masses or abnor-
mal fluid collection.
Segregation of polymorphic markers study at PERFOR-
INE, UNC13D, STXBP2 and SYNTAXIN 11 genes did show
any homozygous haplotype. Sequencing of LIPA gene
revealed homozygous G969A (W130X) mutation leading to
the diagnosis of Wolman disease.
1.2. Patient (2)
Is a 3 month old girl, the second in birth order of double cou-
sin marriage. She had a similar affected brother who died at
the age of 3 months and a maternal cousin (girl) who died at
the age of one month with a provisional diagnosis of FHL
without molecular confirmation, Fig. 1. The patient presented
with abdominal distension, pallor and mild fever (38 C) that
decrease with antipyretics. On examination the patient had
severe failure to thrive, liver was hugely enlarged 6 cm below
the costal margin, and the spleen was 8 cm below the costal
margin. CBC showed hemoglobin level of 6.9 g/dl, total leuko-
cytic count of 5.6  103/mm3 and platelets of 95,000/mm3.
Bone marrow aspiration revealed a marrow infiltrated withgiant macrophages which showed compressed nuclei due to
extensive cytoplasmic vacuolation. These vacuoles contained
unstainable contents. In addition many sea-blue histiocytes
were seen. Phagocytosis of intact and/or damaged hematopoi-
etic cells was rarely seen. The patient had an initial diagnosis of
Niemann–Pick disease and so Beta-glucocerebrosidase enzyme
was done and showed normal level of 5.3 lmol/h/g of protein
(normal 1–5), sphingomyelinase was also measured with the
level of 2.7 umol/gmpt/h (normal 1.5–5 nmol/h/g) excluding
both Niemann–Pick type A and Gaucher disease. Then, the
patient was referred to the genetics clinic because of the family
history of a genetic disease.
Plasma fibrinogen level was 150 mg/dl (normal value: 150–
350), Serum ferritin was 1664 ng/ml (normal; range 10–120),
serum LDH was 1612 U/L (normal range 266–500), serum
triglyceride was 266 mg/dl, ALT was 17 U/ml (normal up o
30), AST was 78 U/ml (normal up to 40), albumin was
2.2 mg/dl.
Segregation of polymorphic markers study at PERFOR-
INE, UNC13D, STXBP2 and SYNTAXIN 11 genes did show
any homozygous haplotype. Sequencing of all coding
sequences of LIPA gene revealed homozygous mutation
c.438delC (p.S112X) leading to the diagnosis of Wolman
disease.
1.3. Patient (3)
Is a 3 month old boy, the third in birth order of first cousin
parents. The pregnancy was uncomplicated and he was deliv-
ered by CS with a birth weight of 3.5 kg. His condition started
at the age of 2.5 months when the mother noticed progressive
abdominal enlargement, failure to thrive and pallor. On exam-
ination, his weight was only 3 kg, length was 52 cm and had no
fever except after one week of presentation (38 C). His liver
Table 1 Comparison between FHL diagnostic criteria and
our patients’ criteria.
Patient 1 Patient 2 Patient 3 FHL [1]
Fever + + + +
Splenomegaly + + + +
Cytopenias
Hemoglobin (g/l) 5 6.9 7.8 <9
Platelets (109/L) 98 95 80 <100
Neutrophils (109/L) 2.5 2.12 3.0 <1.0
Hypertriglyceridemia/
hypofibrinogenemia
Triglycerides (mg/dL) 528 300 947 P265
Fibrinogen – 150 mg/dL 200 mg/dL 61.5 gm/L
Ferritin 2363 ng/ml 1664 ng/ml 2543 ng/ml P500 lg/L
NK cell activity ND ND ND
Wolman disease presenting as FHL 279was enlarged (8.5 cm below the costal margin), firm with
rounded border and smooth surface. His spleen was also
enlarged 8 cm below the costal margin. CBC showed hemoglo-
bin level of 7.8 g/dl, total leukocyte count of 10.5  103/mm3
and platelets of 80,000/mm3. Bone marrow aspiration was
refused by the parents. Plasma fibrinogen level was 200 mg/dl
(normal value: 200–400), Serum ferritin was 2543 ng/ml
(normal range: 7–140), serum triglyceride was 947 mg/dl.
Beta-glucocerebrosidase enzyme was 2.2 lmol/h/g (normal 1–5),
chitotriosidase was 919 umol/L/h (normal 4–84).
A provisional diagnosis of WD was made and so sequencing
of all coding sequencing of LIPA gene revealed homozygous
mutation c.G969A (p.W289X) leading to the diagnosis of
Wolman disease.
Soluble CD25 ND ND ND
Hemophagocytosis in
bone marrow
+  ? +
ND: not done.
The bold signifies the diagnostic criteria of FHLL.2. Discussion
Reports for the association of Wolman disease with HLH are
scarce or underestimated as patients with Wolman disease usu-
ally have short life span that does not permit them to be fully
investigated for the presence of HLH. In this report we
described the clinical and laboratory investigations in three
Egyptian patients with HLH and Wolman disease. To the best
of our knowledge, this is the first report in Egyptian
population.
Al Essa et al. reported the first patient with this association
in 1998 in Saudi Arabia when they described an infant with
Wolman disease, severe anemia and thrombocytopenia,
increased ferritin and both foamy histiocytes and hemophago-
cytic cells in bone marrow [8]. Seven years later, Perry et al.
from Canada studied children with primary adrenal insuffi-
ciency and included two patients with Wolman disease and
presumptive diagnosis of HLH [9]. Another ten years passed
then Rabah et al. described an infant from Oman with this
association in whom Wolman disease diagnosis was confirmed
by enzyme assay but not by molecular testing [10]. At the same
year Taurisano et al. reported another child and explained this
presentation by the tendency of cholesteryl esters- characteris-
tic of Wolman disease – to form crystals and to stimulate acti-
vation of macrophage-mediated inflammation that could be a
trigger of a sustained or acquired HLH which could then be
perpetuated by cytokines and ferritin macrophage production.
According to this explanation, the presence of HLH should be
searched for in every infant with Wolman disease.
In contrast to previous reports, our patients (1 and 2) had a
provisional diagnosis of FHL especially patient 2 had a cousin
with the diagnosis of FHL diagnosis. Ironically patient (1) was
diagnosed with Wolman disease almost 6 months after his
death. The difficulties in diagnosis are attributed to the hetero-
geneous nature of HLH and the similarities of its clinical and
laboratory manifestations to many lysosomal storage diseases
especially when they are present together.
This difficulty and the long time we faced in reaching a
definitive diagnosis (and thereby a proper genetic counseling)
was a challenge that we overcame in the third patient where
our initial diagnosis was Wolman disease and so time and
money were saved and the definitive diagnosis was confirmed
in less than one week.
This was through looking back to patients’ files, where we
noticed that both patients’ fever was not as high as we usually
see in typical FHL patients. Also both patients had huge liversand severe failure to thrive although both did not have the
typical diarrhea of Wolman disease patients.
FHL is a genetically heterogenous disease for which
approximately 30% of individuals diagnosed do not have iden-
tified mutations in any of the four known genes and evidence
of additional loci was provided [11].
The three patients included in this report had clinical and
laboratory criteria of FHL as present in Table 1 while their
molecular testing for the four known gene of FHL revealed
no mutations. We recommend testing of Wolman disease in
patients with FHL negative mutation especially if the fever
is not prominent and is associated with relatively huge
hepatomegaly and/or severe failure to thrive
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